Add Company
Join Now

PlenOptika Revenue and Competitors

License our Company Data API

Boston, MA USA

Location

N/A

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • PlenOptika's estimated annual revenue is currently $7.8M per year.(i)
  • PlenOptika's estimated revenue per employee is $251,000

Employee Data

  • PlenOptika has 31 Employees.(i)
  • PlenOptika grew their employee count by 11% last year.

PlenOptika's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Co FounderReveal Email/Phone
3
VP SalesReveal Email/Phone
4
VP Business Development/Growth InitiativesReveal Email/Phone
5
Product & Project ManagerReveal Email/Phone
6
Ingeniero de desarrollo e investigaciónReveal Email/Phone
7
Product EngineerReveal Email/Phone
8
Técnico electromecánicoReveal Email/Phone
9
Regulatory Affairs SpecialistReveal Email/Phone
10
R&D EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$11M4413%N/AN/A
#2
$11M4429%N/AN/A
#3
$4.3M170%N/AN/A
#4
$3.8M15-29%N/AN/A
#5
$5630M9122-11%$450MN/A
#6
$4.3M170%N/AN/A
#7
$4M16-72%$23.5MN/A
#8
$44.4M1779%N/AN/A
#9
$45.7M1820%N/AN/A
#10
$15M798%$105.2MN/A
Add Company

What Is PlenOptika?

PlenOptika designs innovative technologies to improve vision care globally. Their flagship device the QuickSeeâ„¢ Wavefront Refractor was born at MIT, incubated at Harvard and Boston University, and raised around the world to meet high standards of vision and health care professionals under both rigorous clinical and demanding global health conditions. QuickSee's accuracy has been published in peer-reviewed journals, it has earned international recognition and awards, and it is currently in use by private and nonprofit healthcare organizations internationally. www.plenoptika.com

keywords:N/A

N/A

Total Funding

31

Number of Employees

$7.8M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.2M313%N/A
#2
$6.7M31-9%N/A
#3
$4.5M310%N/A
#4
$6.2M31-11%N/A
#5
$6.7M3111%N/A